A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19

Am J Cardiol. 2020 Sep 1:130:159-161. doi: 10.1016/j.amjcard.2020.05.038. Epub 2020 Jun 2.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Angiotensin Receptor Antagonists / adverse effects*
  • Angiotensin-Converting Enzyme 2
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / mortality
  • Humans
  • Pandemics
  • Peptidyl-Dipeptidase A
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / mortality
  • Renin-Angiotensin System
  • Risk Factors
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2